2026 EU-Y2 SCHEDULE
AT A GLANCE

Final program is subject to change

  • THURSDAY – NOVEMBER 12, 2026

  • 9:00 AM EST

    Welcome from AACE President

  • 9:05 AM EST

    Opening Remarks

  • 9:10 AM – 11:10 AM EST
    Pituitary Lectures

    9:10 AM - Functional Pituitary Tumors

    9:50 AM - Cushing Syndrome

    10:30 AM - Evaluation and Management of Panhypopituitarism

  • 11:10 AM – 11:25 AM EST
    Break
  • 11:25 AM – 12:10 PM EST
    Pituitary Case Discussions

    Case Management of Functional Tumors, Group 1

    Case Management of Functional Tumors, Group 2

    Cushing Syndrome, Group 1

    Cushing Syndrome, Group 2

    Diabetes Insipidus (DI) / SIADH

    Evaluation and Management of Panhypopituitarism

  • 12:15 PM – 2:15 PM EST
    Adrenal Lectures

    1:45 PM - Adrenal Insufficiency

    2:25 PM - Diagnostic Evaluation of Pheochromocytoma

    3:05 PM - Hyperaldosteronism

  • 2:15 PM – 2:20 PM EST
    Break
  • 2:20 PM – 3:05 PM EST
    Adrenal Case Discussions

    Adrenal Insufficiency

    Adrenal Tumors

    Adrenocortical Carcinoma

    Congenital Adrenal Hyperplasia

    Genetic Disorders of the Adrenal Medulla

  • 3:10 PM – 4:10 PM EST
    Product Theaters

    4:25 PM - Product Theater 1

    5:15 PM - Product Theater 2

    6:05 PM - Product Theater 3

  • FRIDAY – NOVEMBER 13, 2026

  • 10:00 AM EST

    Day 2 Welcome

  • 10:15 AM – 12:45 PM EST
    Reproductive Lectures

    10:15 AM - Reproductive Endocrinology Disorders

    11:05 AM - Male Hypogonadism: Diagnosis and Management

    11:55 AM - Transgender Health for Endocrinologists

  • 12:45 PM – 1:00 PM EST
    Break
  • 1:00 PM – 1:50 PM EST
    Reproductive Case Discussions

    Evaluation and Management of Premature Ovarian Failure (POF) and Menopause

    Gynecomastia

    Hyperandrogenism in Women, Including PCOS

    Infertility Evaluation

    Male Hypogonadism

    Transgender Management

  • 1:50 PM – 2:35 PM EST
    Thyroid Cancer

    1:50 PM - Medullary Thyroid Cancer

  • 2:35 PM – 4:35 PM EST
    Bone Lectures

    2:35 PM - Clinical Approach to Metabolic Bone Disease

    3:15 PM - Pharmacologic Approaches to Osteoporosis

    3:55 PM - Renal Bone Disease and Transplant Osteoporosis

  • 4:35 PM – 4:45 PM EST
    Break
  • 4:45 PM – 5:30 PM EST
    Bone Case Discussions

    Disorders of Hypocalcemia and Hypophosphatemia

    Prevention and Treatment of Osteoporosis, Group 1

    Prevention and Treatment of Osteoporosis, Group 2

    Rare Bone Disorders

    Secondary Osteoporosis Including Hyperparathyroidism, Group 1

    Secondary Osteoporosis Including Hyperparathyroidism, Group 2

  • 5:45 PM EST
    Product Theaters

  • SATURDAY – NOVEMBER 14, 2026

  • 9:00 AM – 9:05 AM EST

    Opening Remarks

  • 9:05 AM – 10:00 AM EST

    Update in Diabetes

  • 10:00 AM – 12:00 PM EST
    Lipid Lectures

    10:00 AM - Lipid Physiology and Pathogenesis of Monogenic Lipid Disorders

    10:40 AM - Landmark Lipid Trials and Current Lipid Treatment Guidelines

    11:20 AM - Residual Risk and Novel Therapies

  • 12:00 PM – 12:15 PM EST
    Break
  • 12:15 PM – 1:00 PM EST
    Lipids Case Discussions

    Disorders of Lipoprotein Metabolism, Group 1

    Disorders of Lipoprotein Metabolism, Group 2

    Dyslipidemia and Diabetes

    Management of Hypercholesterolemia

    Management of Hypertriglyceridemia

  • 1:05 PM – 2:25 PM EST
    Obesity Lectures

    1:05 PM - Obesity Genetics and Pathophysiology

    1:45 PM - Surgical and Medical Management of Obesity

  • 2:25 PM – 2:35 PM EST
    Break
  • 2:35 PM – 3:20 PM EST
    Obesity Case Discussions

    Disorders of Obesity

    Medical Management of Obesity, Group 1

    Medical Management of Obesity, Group 2

    Surgical Management of Obesity

  • 3:20 PM EST

    Closing Remarks

Final program is subject to change